Binding to protein surfaces by supramolecular multivalent scaffolds

Current Opinion in Chemical Biology

Volumn 12, Issue 6, 2008, Pages 698-706

  Martos, Vera ^a,b   Castreño, Pilar ^a   Valero, Julián ^a,c   de Mendoza, Javier ^a,b  

^a INSTITUTE OF CHEMICAL RESEARCH OF CATALONIA ICIQ   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALIXARENE; LECTIN; NANOPARTICLE; POLYCYCLIC AROMATIC HYDROCARBON; POLYMER; POLYROTAXANE; PORPHYRIN; ROTAXANE; RUTHENIUM; SCAFFOLD PROTEIN; TAXANE DERIVATIVE; TOXIN; UNCLASSIFIED DRUG;

CATALYSIS; IN VITRO STUDY; POLYMERIZATION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; RING CLOSING METATHESIS; SUPRAMOLECULAR CHEMISTRY;

ANIMALS; CATALYSIS; HUMANS; INORGANIC CHEMICALS; ORGANIC CHEMICALS; PROTEIN BINDING; PROTEINS;

EID: 57549110044     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2008.08.024     Document Type: Review

References (63)

1. Bogan A.A., and Thorn K.S. Anatomy of hot spots in protein interfaces. J Mol Biol 280 (1998) 1-9
2. Mammen M., Choi S.K., and Whitesides G.M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed 37 (1998) 2754-2794
3. Kiessling L.L., Gestwicki J.E., and Strong L.E. Synthetic multivalent ligands as probes of signal transduction. Angew Chem Int Ed 45 (2006) 2348-2368. An excellent review summarizing the most relevant examples of multivalent interactions from the mechanistic and biological points of view.
4. Huskens J. Multivalent interactions at interfaces. Curr Opin Chem Biol 10 (2006) 537-543
5. Badjic J.D., Nelson A., Cantrill S.J., Turnbull W.B., and Stoddart J.F. Multivalency and cooperativity in supramolecular chemistry. Acc Chem Res 38 (2005) 723-732
6. Mandolini L. Intramolecular reactions of chain molecules. Adv Phys Org Chem 22 (1986) 1-111
7. Chi X., Guerin A.J., Haycock R.A., Hunter C.A., and Sarson L.D. The thermodynamics of self-assembly. Chem Commun (1995) 2563-2565
8. Krishnamurthy V.M., Semetey V., Paul J.B., Shen N., and Whitesides G.B. Dependence of effective molarity on linker length for an intramolecular protein-ligand system. J Am Chem Soc 129 (2007) 1312-1320. This paper brings into play thermodynamic clues of the design and study of multivalent protein ligands.
9. Fletcher S., and Hamilton A.D. Targeting protein-protein interactions by rational design: mimicry of protein surfaces. J R Soc Interface 3 (2006) 215-233. The authors present an excellent account on protein surface binding by small multivalent supramolecular scaffolds and by mimics of secondary peptide structures.
10. 50 activity.
11. Francese S., Cozzolinoc A., Caputo I., Esposito C., Martino M., Gaeta C., Troisi F., and Neri P. Transglutaminase surface recognition by peptidocalix[4]arene diversomers. Tetrahedron Lett 46 (2005) 1611-1615
12. Arosio D., Fontanella M., Baldini L., Mauri L., Bernardi A., Casnati A., Sansone F., and Ungaro R. A synthetic divalent Cholera toxin glycocalix[4]arene ligand having higher affinity than natural GM1 oligosaccharide. J Am Chem Soc 127 (2005) 3660-3661
13. André S., Sansone F., Kaltner H., Casnati A., Kopitz J., Gabius H.-J., and Ungaro R. Calix[n]arene-based glycoclusters: bioactivity of thiourea-linked galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell-surface glycoconjugates and selectivity among human adhesion/growth-regulatory galectins. ChemBioChem 9 (2008) 1649-1661. The interaction of 14 calix[n]arenes endowed with a number of galactose or lactose derivatives with lectins - either bio-hazardous or acting as factors in tumor progression - is thoroughly studied. Interestingly, a preference for lactose over galactose epitopes, glycoside cluster effects, and a dependence of selective lectin inhibition on shape and valency of the glycoclusters are revealed.
14. Salvatella X., Peczuh M.W., Gairí M., Jain R.K., Sánchez-Quesada J., de Mendoza J., Hamilton A.D., and Giralt E. Side chain elongation causes a change in enthalpy driven entropy binding in the molecular recognition of tetraanionic peptides. Chem Commun (2000) 1399-1400
15. Orner B.P., Salvatella X., Sánchez-Quesada J., de Mendoza J., Giralt E., and Hamilton A.D. De novo protein surface design: use of cation-π interactions to enhance binding between an alfa-helical peptide and a cationic molecule in 50% aqueous solution. Angew Chem Int Ed 41 (2002) 117-119
16. Salvatella X., Martinell M., Gairí M., Mateu M.G., Feliz M., Hamilton A.D., de Mendoza J., and Giralt E. A tetraguanidinium ligand binds to the surface of the tetramerization domain of protein P53. Angew Chem Int Ed 43 (2004) 196-198. This paper shows how the rational design serves to target a well-defined sequence in the tetramerization domain of p53 by multivalent ligands.
17. Gordo S, Martos V, Santos E, Menéndez M, Bo C, Giralt E, de Mendoza J: Stability and structural recovery of the tetramerization domain of p53-R337H mutant induced by a designed templating ligand. Proc Natl Acad Sci USA 2008, 105:in press.
18. Tomiteta N., Sando S., Sera T., and Aoyama Y. Macrocyclic proteoglycan mimics. Potent inhibition of cell adhesion by a bundle of chondroitin sulfate chains assembled on the calix[4]resorcarene platform. Bioorg Med Chem Lett 14 (2004) 2087-2090
19. Mecca T., Consoli G.M.L., Geraci C., and Cunsolo F. Designed calix[8]arene-based ligands for selective tryptase surface recognition. Bioorg Med Chem 12 (2004) 5057-5062
20. Mecca T., Consoli G.M.L., Geraci C., LaSpina R., and Cunsolo F. Polycationic calix[8]arenes able to recognize and neutralize heparin. Org Biomol Chem 4 (2006) 3763-3768
21. Hershberger S., Lee S.-G., and Chmielewski J. Scaffolds for inhibiting protein-protein interactions. Curr Top Med Chem 7 (2007) 928-942. This review is worthwhile reading and a good complement to Ref. [9].
22. Tagore D.M., Sprinz K.I., Fletcher S., Jayawickramarajah J., and Hamilton A.D. Protein recognition and denaturation by self-assembling fragments on a DNA quadruplex scaffold. Angew Chem Int Ed 46 (2007) 223-225. This is an interesting attempt to substitute porphyrins scaffolds by naturally occurring selfassembling DNA motifs. It is inspired in previous studies that design porphyrin ligands to bind to telomerase-binding G-quartets.
23. Zhou H., Baldini L., Hong J., Wilson A.J., and Hamilton A.D. Pattern recognition of proteins based on an array of functionalized porphyrins. J Am Chem Soc 128 (2006) 2421-2425
24. Gradl S.N., Felix J.P., Isacoff E.Y., Garcia M.L., and Trauner D. Protein surface recognition by rational design: nanomolar ligands for potassium channels. J Am Chem Soc 125 (2003) 12668-12669
25. + channel. Nat Struct Mol Biol 15 (2008) 605-612
26. Kano K., and Ishida Y. Supramolecular complex of Cytochrome C with a polyanionic β-cyclodextrine. Angew Chem Int Ed 46 (2007) 727-730
27. Xu Y., Lu H., Kennedy J.P., Yan X., McAllister L.A., Yamamoto N., Moss J.A., Boldt G.E., Jiang S., and Janda K.D. Evaluation of "credit card" libraries for inhibition of HIV-1 gp41 fusogenic core formation. J Comb Chem 8 (2006) 531-539
28. Wilson A.J., Hong J., Fletcher S., and Hamilton A.D. Recognition of solvent exposed protein surfaces using anthracene derived receptors. Org Biomol Chem 5 (2007) 276-285
29. Hayashida O., and Uchiyama M. Multivalent macrocyclic hosts: histone surface recognition, guest binding, and delivery by cyclophane-based resorcinarene oligomers. J Org Chem 72 (2007) 610-616. In this example negatively charged dendrimer-like molecules recognize histones through ionic interactions with the positively charged histone surface. However, the cyclophane scaffold also contributes to approach molecules to the interaction site, and thus the scaffold is not limited to a structural function.
30. Hayashida O., Ogawa N., and Uchiyama N. Surface recognition and fluorescence sensing of histone by dansyl-appended cyclophane-based resorcinarene trimer. J Am Chem Soc 129 (2007) 13698-13705
31. Specker D., and Wittman V. Synthesis and application of glycopeptide and glycoprotein mimetics. Top Curr Chem 267 (2007) 65-107. A good and brief review on the latest progress in the field.
32. Heegaard P.M.H., and Boas U. Dendrimer based anti-infective and anti-inflammatory drugs. Recent Patents Anti-Infect Drug Discov 1 (2006) 331-351
33. Li Y., Cheng Y., and Xu T. Design, synthesis and potent pharmaceutical applications of glycodendrimers: a mini review. Curr Drug Discov Technol 4 (2007) 246-254
34. •].
35. •].
36. •], this paper constitutes a thorough update on glycodendrimers since 2000 from the chemist point of view.
37. Shane L., and Cloninger M.J. Binding of monomeric and dimeric concavalin A to mannose-funtionalized dendrimers. Org Biomol Chem 4 (2006) 2458-2465
38. Mori T., Hatano K., Matsuoka K., Esumi Y., Toone E.J., and Terunuma D. Synthesis of carbosilane dendrimers having peripheral mannose and mannobiose. Tetrahedron 61 (2005) 2751-2760
39. Pukin A.V., Branderhorst H.M., Sisu C., Weijers C.A.G.M., Gilbert M., Liskamp R.M.J., Visser G.M., Zuilhof H., and Pieters R.J. Strong inhibition of Cholera toxin by multivalent GM1 derivatives. ChemBioChem 8 (2007) 1500-1503. GM1-oligosaccharide (GM1os), an optimal ligand for CT, was linked to dendritic structures endowed with long arms by using highly efficient 'click chemistry' coupling. Very large multivalency effects were observed, the best structure showing unprecedented 380 000-fold more potent ligand for the toxin than for a monovalent GM1os reference.
40. Podlipnik C., Velter I., La Ferla B., Marcou G., Belvisi L., Nicotra F., and Bernardi A. First round of a focused library of Cholera toxin inhibitors. Carbohydr Res 342 (2007) 1651-1660
41. Branderhorst H.M., Liskamp R.M.J., Visser G.M., and Pieters R.J. Strong inhibition of Cholera toxin binding by galactose dendrimers. Chem Commun (2007) 5043-5045
42. Dubber M., Sperling O., and Lindhorst T.K. Oligomannoside mimetics by glycosylation of octopus glycosides and their investigation as inhibitors of type 1 fimbriae-mediated adhesion of Escherichia coli. Org Biomol Chem 4 (2006) 3901-3912
43. Koehn M., Benito J.M., Mellet C.O., Lindhorst T.K., and Fernandez J.M.G. Functional evaluation of carbohydrate-centred glycoclusters by enzyme-linked lectin assay: ligands for Concanavalin A. ChemBioChem 5 (2004) 771-777
44. Gouin S.G., Vanquelef E., García Fernández J.M., Ortiz Mellet C., Dupradeau F.-Y., and Kovensky J. Multi-mannosides based on a carbohydrate scaffold: synthesis, force field development, molecular dynamics studies, and binding affinities for lectin Con A. J Org Chem 72 (2007) 9032-9045
45. Kitov P.I., Sadowska J.M., Mulvey G., Arnstrong G.D., Ling H., Pannu N.S., Read R.J., and Bundle D.R. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands. Nature 403 (2000) 669-672
46. Williams S.J., and Davies G.J. Protein-carbohydrate interactions: learning lessons from nature. Trends Biotechnol 19 (2001) 356-362
47. Mulvey G.L., Marcato P., Kitov P.I., Sadowska D.R., Budle D.R., and Armstrong J. Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands. J Infect Dis 187 (2003) 640-649
48. Solomon D., Kitov P.I., Paszkiewicz E., Grant G.A., Sadowska J.M., and Bundle D.R. Heterobifunctional multivalent inhibitor-adaptor mediates specific aggregation between Shiga toxin and a pentraxin. Org Lett 7 (2005) 4369-4372
49. Kitov P.I., Lipinski T., Paszkiewicz E., Solomon D., Sadowska J.M., Grant G.A., Mulvey G.L., Kitova E.N., Klassen J.S., Armstrong G.D., and Bundle D.R. An entropically efficient supramolecular inhibition strategy for Shiga toxins. Angew Chem Int Ed 47 (2008) 672-676. An original proposal of a multivalent ligand simultaneously interacting with two proteins that would not approach one another in its absence. A recent contribution to a successful research started a decade ago (see Ref. [45]).
50. Shcharbin D., Janicka M., Wasiak M., Palecz B., Przybyszewska M., Zaborski M., and Bryszewska M. Serum albumins have five sites for binding of cationic dendrimers. Biochim Biophys Acta Proteins Proteomics 1774 (2007) 7946-7951
51. Klajnert B., Cangiotti M., Calici S., Majoral J.P., Caminade A.M., Cladera J., Bryszewska M., and Ottaviani M.F. EPR study of the interactions between dendrimers and peptides involved in Alzheimer's and Prion diseases. Macromol Biosci 7 (2007) 1065-1074
52. 5 are described.
53. Arendt M., Sun W., Thomann J., Xie X., and Schrader T. Dendrimeric bisphosphonates for multivalent protein surface binding. Chem Asian J 1 (2006) 544-554
54. Bertozzi C.R., and Kiessling L.L. Chemical glycobiology. Science 291 (2001) 2357-2364
55. Puffer E.B., Pontrello J.K., Hollenbeck J.J., Kink J.A., and Kiessling L.L. Activating B cell signaling with defines multivalent ligands. Chem Biol 2 (2007) 252-262
56. Nelson A., Belitsky J.M., Vidal S., Joiner C.S., Baum L.G., and Stoddart J.F. A self-assembled multivalent pseudopolyrotaxane for binding Galectin-1. J Am Chem Soc 126 (2004) 914-11922
57. Ooya T., Utsunomiya H., Eguchi M., and Yui N. Rapid binding of Concanavalin A and maltose-polyrotaxane conjugates due to mobile motion of α-cyclodextrins threaded onto a poly(ethylene glycol). Bioconjug Chem 16 (2005) 62-69
58. Yui N., and Ooya T. Molecular mobility of interlocked structures exploiting new functions of advanced biomaterials. Chem Eur J 12 (2006) 6730-6737. An interesting application of polyrotaxanes namely cyclic compounds rotating and/or sliding along a polymeric backbone. The mobility of ligands linked to the wheeled compounds is the key for the enhancement of multivalent interactions with biomacromolecules.
59. You C.-C., De M., Han G., and Rotello V.M. Tunable inhibition and denaturation of α-chymotrypsin with amino acid-functionalized gold nanoparticles. J Am Chem Soc 127 (2005) 12873-12881
60. You C.C., Agasti S.S., and Rotello V.M. Isomeric control of protein recognition with amino acid- and dipeptide-functionalized gold nanoparticles. Chem Eur J 14 (2008) 143-150
61. •].
62. •].
63. •], this work clearly stresses the advantages (easy synthetic access and a reduced toxicity) of gold nanoparticles as the platforms for multivalent ligands. However, the previous design or a combinatorial selection of REs is still a requirement to complement the specific polar, hydrophobic, and topological requisites of protein surface binding.